These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23704707)

  • 1. Granulomatous mass adherent to a patent foramen ovale occluder.
    Ancedy Y; Bernard Brunet A; Quilliet L; Mirza A; Fauchier L
    Eur Heart J; 2013 Aug; 34(29):2251. PubMed ID: 23704707
    [No Abstract]   [Full Text] [Related]  

  • 2. Foreign body granuloma as an unexpected long-term finding after percutaneous closure of a patent foramen ovale.
    Besler C; Bakhtiary F; Linke A; Zimmer M
    Eur Heart J; 2017 Dec; 38(46):3472-3473. PubMed ID: 28369276
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombus formation on the Amplatzer device: a need for critical attitude in percutaneous patent ovale closure decision-making.
    Ciurus T; Piestrzeniewicz K; Maciejewski M; Łuczak K; Jakubowski P; Drożdż J
    Eur Heart J; 2015 May; 36(19):1195. PubMed ID: 25433024
    [No Abstract]   [Full Text] [Related]  

  • 4. Subacute endocarditis of an atrial septal closure device in a patient with a patent foramen ovale.
    Krantz SB; Lawton JS
    Ann Thorac Surg; 2014 Nov; 98(5):1821-3. PubMed ID: 25441794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late left atrial thrombosis of an Amplatzer patent foramen ovale occluder.
    Klotz S; Gebhard M; Sievers HH
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1270-1. PubMed ID: 21724200
    [No Abstract]   [Full Text] [Related]  

  • 6. Late failure of Amplatzer device closure of a patent foramen ovale.
    Unai S; Bajwa G; Fischman DL; Entwistle JW; Hirose H
    J Card Surg; 2014 Nov; 29(6):801-2. PubMed ID: 25109750
    [No Abstract]   [Full Text] [Related]  

  • 7. Amplatzer occluder versus CardioSEAL/STARFlex occluder: a meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect.
    Li Y; Zhou K; Hua Y; Wang C; Xie L; Fang J; Rong X; Shen J
    Cardiol Young; 2013 Aug; 23(4):582-96. PubMed ID: 23199453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymptomatic embolized HELEX PFO closure device: catheter based retrieval and value of routine echocardiography the following day.
    Moukarbel GV; Kitkungvan D; Safiia MA; Aragam J; Kinlay S
    Int J Cardiol; 2012 Jul; 158(3):e57-9. PubMed ID: 22104997
    [No Abstract]   [Full Text] [Related]  

  • 9. The BioSTAR(r) device versus the CardioSEAL(r) device in patent foramen ovale closure: comparison of mid-term efficacy and safety.
    Van den Branden BJ; Luermans JG; Post MC; Plokker HW; Ten Berg JM; Suttorp MJ
    EuroIntervention; 2010 Sep; 6(4):498-504. PubMed ID: 20884438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very late patent foramen ovale occluder device embolization.
    Gaspardone A; Giardina A; Gioffrè G; Iamele M; Borioni R
    J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):282-4. PubMed ID: 21386687
    [No Abstract]   [Full Text] [Related]  

  • 11. Left Atrial Thrombus Associated With Interatrial Septal Occluder 5 Years After Implantation.
    Misra S; Conte J; Resar J
    Circ Cardiovasc Interv; 2015 Oct; 8(10):e002856. PubMed ID: 26399266
    [No Abstract]   [Full Text] [Related]  

  • 12. Device-Associated Left Atrial Thrombosis Despite Oral Anticoagulation After Percutaneous Patent Foramen Ovale Closure.
    Tzimas G; Muller O; Kirsch M; Monney P
    Can J Cardiol; 2019 Nov; 35(11):1605.e5-1605.e6. PubMed ID: 31679631
    [No Abstract]   [Full Text] [Related]  

  • 13. Recurrence of cryptogenic stroke or TIA in patients with patent foramen ovale successfully treated by using different kind of percutaneous occluder devices: five-year follow-up.
    de Cillis E; Acquaviva T; Basile DP; Cipriani F; Bortone AS
    Minerva Cardioangiol; 2010 Aug; 58(4):425-31. PubMed ID: 20938409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case images: percutaneous retrieval of an embolized occluder device from the aorta using a goose-neck snare.
    Yıldırır A; Varan B; Erdoğan I; Boyvat F
    Turk Kardiyol Dern Ars; 2012 Jun; 40(4):393. PubMed ID: 22951862
    [No Abstract]   [Full Text] [Related]  

  • 15. [Simultaneous percutaneous closure of patent foramen ovale and left atrial appendage].
    Paulo M; García E; Hernández-Antolín RA; Almería C
    Rev Esp Cardiol; 2011 Dec; 64(12):1215-6. PubMed ID: 21601977
    [No Abstract]   [Full Text] [Related]  

  • 16. Late erosion of an Amplatzer septal occluder device 6 years after placement.
    Taggart NW; Dearani JA; Hagler DJ
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):221-2. PubMed ID: 21463878
    [No Abstract]   [Full Text] [Related]  

  • 17. Transcatheter Closure of Patent Foramen Ovale.
    Price MJ
    Interv Cardiol Clin; 2017 Oct; 6(4):ix-x. PubMed ID: 28886847
    [No Abstract]   [Full Text] [Related]  

  • 18. Removal of patent foramen ovale occluder with adherent left atrial thrombus.
    Kapelak B; Wrobel K; Wegrzyn P; Sadowski J
    Eur J Cardiothorac Surg; 2009 Feb; 35(2):363. PubMed ID: 19084421
    [No Abstract]   [Full Text] [Related]  

  • 19. Percutaneous reclosure of a patent foramen ovale after bioabsorbable device implantation.
    Snijder RJ; Post MC; Suttorp MJ
    EuroIntervention; 2014 Nov; 10(7):860. PubMed ID: 24469307
    [No Abstract]   [Full Text] [Related]  

  • 20. Closing one hole leads to another: delayed aortic perforation following closure of a patent foramen ovale.
    Kimmelstiel C
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):135-6. PubMed ID: 20578219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.